Literature DB >> 18664194

[Emodin induces apoptosis of cancer cells and inhibits retinoid X receptor transcriptional activity].

Fu-Lin He1, Li Wang, Xiao-Kun Zhang, Jing-Zhang Zeng.   

Abstract

The mechanisms by which emodin induces apoptosis and inhibits proliferation of cancer cells remain unclear. In this study, we investigated whether the proapoptotic effect of emodin on human NIH-H460 lung cancer cells and SMMC-7721 liver cancer cells was related to regulating RXR expression and function. MTT assay and DAPI staining were used to detect the anti-proliferative and apoptotic effects of emodin with or without 9-cis-retinoid acid on H460 and SMMC-7721. The reporter assay was used to detect the effect of emodin on RXR homo- and hetero-dimer transactivation. Competitive ligand binding assay was carried out to detect whether emodin could directly bind to RXR. The result showed that emodin could strongly inhibit the proliferation and induce apoptosis of both cancer cell lines, which could be antagonized by 9-cis-RA. The reporter assay showed that emodin could inhibit the transcriptional effect of the homo- and hetero-dimer transactivation of RXRalpha dose-dependently. However, in vitro binding assay did not show that emodin bind to RXRalpha-LBD directly. The findings suggest that exhibition of emodin its anti-cancer activity may be associated with involvement of RXRalpha signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664194

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  3 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV.

Authors:  Shuang-Suo Dang; Xiao-Li Jia; Ping Song; Yan-An Cheng; Xin Zhang; Ming-Zhu Sun; En-Qi Liu
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 3.  Quinonoids: Therapeutic Potential for Lung Cancer Treatment.

Authors:  Hua-Zhong Ying; Chen-Huan Yu; Hao-Kun Chen; Huan-Huan Zhang; Jie Fang; Fang Wu; Wen-Ying Yu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.